SlideShare une entreprise Scribd logo
1  sur  30
Heavy metal and Heavy metal antagonists
Heavy metals of concern are Lead Mercury Arsenic Cadmium Exert there toxic effects by combining with one or more reactive groups (Ligands) essential for normal physiological functions. Heavy metals may react in the body with- Ligands containing Oxygen-  -OH, -COO -  Ligand containing  Sulfur-  -SH Ligand containing Nitrogen-  -NH 2
Heavy metal antagonists (Chelating agents) are designed specifically to compete with these groups for the metals and prevent  or reverse toxic effects and enhance the excretion of metals.  Chelate - complex formed b/w a metal and a compound that contains two or more potential ligands. The stability of chelate varies with the metal and the ligand atoms. e.g- lead and mercury have greater affinities for sulfur and  nitrogen than for oxygen.
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
LEAD Primary source- leaded paints and drinking water environmental & industrial exposure Absorption, distribution and excretion Absorption  –  g.i.t & the respiratory system g.i.t absorption varies with age- Adults absorb upto 10% of ingested lead Children absorb upto 40% of ingested lead Iron deficiency also enhance intestinal absorption of lead.
Distribution Once lead is absorbed , about 99% of that in the blood stream binds to hemoglobin in erythrocytes. initial distribution  – in the soft tissues particularly tubular  epithelium  of kidney and in the liver In time-  redistributed and deposited in bone, teeth & hair.  Excretion-  urinary excretion Because most of the lead is in the erythrocytes, very little is Filtered lead is also excreted in milk & sweat. Placental transfer of lead is also known.
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Acute hemolytic crisis sometimes occurs & cause severe anemia & hemoglobinuria. The kidneys are damaged & urinary changes are evident death may Occur in 1-2 days. CHRONIC LEAD POISONING Signs and symptoms may be divided into six categories 1.  Gastrointestinal  - Anorexia Muscle discomfort headache Constipation usually is an early sign
2 .  Neuromuscular  –  muscle weakness easy fatigue occur long before actual paralysis 3.  CNS-  lead encephalopathy Most serious menifestation specially in children than in adults Early signs-  vertigo, insomnia, restlessness, headache,  irritability As encephalopathy develops- - patient may first become excited & confused -delirium with repetitive  tonic-clonic convulsions  & coma follows. -vomiting a common sign -visual disturbances
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Succinyl CoA + Glycine δ-aminolevulinate synthase δ-aminolevulinate (δ-ALA) δ-aminolevulinate dehydratase Porphobilinogen Uroporphobilinogen Coproporphyrinogen Protoporphyrin ferrochelatase +Fe 2+ Heme
Diagnosis of lead poisoning -Children –  lead in blood > 10µg/dl are at risk of  Developmental disabilities -Adults-  concentration >30µg/dl functional injury or  Symptoms -Decrease in δ-aminolevulinate dehydratase activity - Increase in urinary excretion of  δ-ALA & increase in  Erythrocyte protoporphyrin Patients with lead concentration 30-75µg/dl have all the Above laboratory abnormality
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
1)  CaNa 2 EDTA - initiated at  a dose of 30-50mg/kg per day  divided in two doses,either by deep i.m injection  or slow i.v infusion for 5  consecutive days The first dose of  CaNa 2 EDTA should be delayed until 4 hrs after  the first dose of dimercaprol. An  additional course may be given after an interruption of 2 days Each course of therapy should not exceed a total dose of 500mg/kg 2)  Dimercaprol - 4mg/kg i.m route every 4 hrs for 48 hrs, then  every every 6hrs for 48 hrs finally every 6-12 hrs for additional  7 days.
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Mechanism of action- It readly forms covalent bond with sulfur, & it is this property that accounts for most of the biological properties of the metal. Also combines with phosphoryl, carboxyl, amide and amine group.
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Concentration in urine-  normal 5µg/liter TREATMENT Inorganic mercury  - maintenance of fluid & electrolyte balance -emesis can be induced if patient is awake & alert chelation therapy Dimercaprol - 5mg/kg i.m initially,followed by 2.5mg/kg i.m every 12-24 hrs for 10 days.  OR Penicillamine  – 250mg orally every 6 hours
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
ARSENIC - Found in soil, water and air as a common environmental  Toxicant -Major source of occupational exposure to arsenic –containing Compounds is from manufacture of arsenical herbicides & pesticides. Mechanism of action Arsenate (pentavalent) is a well known uncoupler of mitochondrial oxidative phosphorylation. There is competitive substitution of arsenate for  inorganic  Phosphate in the formation of adenosine triphosphate
Subsequent formation of an unstable arsenate ester that is rapidly hydrolysed (Arsenolysis). Toxicological effects of arsenic CVS-  Acute & subacute doses induces mild vasodilation this leads to an edema, particularly facial. -hypotention -congestive heart failure -cardiac arrythmias GIT - -mild abdominal cramping -diarrhoea -severe gastroentritis  associated with shock.
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Kidneys Severe renal damage Skin Hyperpigmentation in raindrop pattern Nervous system Encephalopathy Neurological lesions Liver-  necrosis Carcinogenesis-  skin tumors
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
-nausea -vomiting -salivation -abdominal cramps Symptoms that appear in a few hours - irritation of respiratory tract with severe,early pneumonitis -chest pain -dizziness
Chronic cadmium poisoning Kidney - proximal tubular injury proteinuria Lung - dyspnea Bone-  osteomalacia Testis - testicular necrosis Treatment of cadmium poisoning - remove the patient from source -respiratory support
[object Object],[object Object],[object Object],[object Object],[object Object]

Contenu connexe

Tendances

Toxicities and manag. of poisonings (heavy metals)
Toxicities and manag. of poisonings (heavy metals)Toxicities and manag. of poisonings (heavy metals)
Toxicities and manag. of poisonings (heavy metals)
Subramani Parasuraman
 
Organophosphorous poisoning
Organophosphorous poisoningOrganophosphorous poisoning
Organophosphorous poisoning
frooty21
 

Tendances (20)

Pharmacotherapy of asthma and copd
Pharmacotherapy of asthma and copdPharmacotherapy of asthma and copd
Pharmacotherapy of asthma and copd
 
Toxicities and manag. of poisonings (heavy metals)
Toxicities and manag. of poisonings (heavy metals)Toxicities and manag. of poisonings (heavy metals)
Toxicities and manag. of poisonings (heavy metals)
 
Barbiturate & Morphine poisoning
Barbiturate & Morphine poisoningBarbiturate & Morphine poisoning
Barbiturate & Morphine poisoning
 
Respiratory stimulants
Respiratory stimulantsRespiratory stimulants
Respiratory stimulants
 
Organophosphorous poisoning
Organophosphorous poisoningOrganophosphorous poisoning
Organophosphorous poisoning
 
Respiratory pharmacology (anti asthmatic drugs)
Respiratory pharmacology (anti asthmatic drugs) Respiratory pharmacology (anti asthmatic drugs)
Respiratory pharmacology (anti asthmatic drugs)
 
Principles of toxicology
Principles of toxicologyPrinciples of toxicology
Principles of toxicology
 
Opioid Poisoning and treatment-By Prafull Jain
Opioid Poisoning and treatment-By Prafull JainOpioid Poisoning and treatment-By Prafull Jain
Opioid Poisoning and treatment-By Prafull Jain
 
Cardiovascular Drugs (Medicinal Chemistry) MANIK
Cardiovascular Drugs (Medicinal Chemistry) MANIKCardiovascular Drugs (Medicinal Chemistry) MANIK
Cardiovascular Drugs (Medicinal Chemistry) MANIK
 
Drug discovery, drug design and drug development (drug optimization) of ACEI ...
Drug discovery, drug design and drug development (drug optimization) of ACEI ...Drug discovery, drug design and drug development (drug optimization) of ACEI ...
Drug discovery, drug design and drug development (drug optimization) of ACEI ...
 
Basic definition and types of toxicology
Basic definition and types of toxicologyBasic definition and types of toxicology
Basic definition and types of toxicology
 
Histamine and antihistaminics
Histamine and antihistaminicsHistamine and antihistaminics
Histamine and antihistaminics
 
Antileprotic drugs
Antileprotic drugsAntileprotic drugs
Antileprotic drugs
 
MEDICINAL CHEMISTRY-I(BP402T)
MEDICINAL CHEMISTRY-I(BP402T)MEDICINAL CHEMISTRY-I(BP402T)
MEDICINAL CHEMISTRY-I(BP402T)
 
Excretion of drugs and kinetics of elimination
Excretion of drugs and kinetics of eliminationExcretion of drugs and kinetics of elimination
Excretion of drugs and kinetics of elimination
 
General principles in treatment of common drug poisoining
General principles in treatment of common drug poisoining General principles in treatment of common drug poisoining
General principles in treatment of common drug poisoining
 
Macrolide antibiotics
Macrolide antibioticsMacrolide antibiotics
Macrolide antibiotics
 
drug interactions
drug interactionsdrug interactions
drug interactions
 
Adrenergic drugs
Adrenergic drugsAdrenergic drugs
Adrenergic drugs
 
Macroloid antibiotics
Macroloid antibioticsMacroloid antibiotics
Macroloid antibiotics
 

Similaire à Heavy metal and heavy metal antagonists

Similaire à Heavy metal and heavy metal antagonists (20)

Heavy metal poisoning
Heavy metal poisoningHeavy metal poisoning
Heavy metal poisoning
 
Copper.pptx
Copper.pptxCopper.pptx
Copper.pptx
 
ARSENIC-AIIMS KALYANI.pptx
ARSENIC-AIIMS KALYANI.pptxARSENIC-AIIMS KALYANI.pptx
ARSENIC-AIIMS KALYANI.pptx
 
Opioid Poisoninig ppt.pptx
Opioid Poisoninig ppt.pptxOpioid Poisoninig ppt.pptx
Opioid Poisoninig ppt.pptx
 
toxic chemical.pdf
toxic chemical.pdftoxic chemical.pdf
toxic chemical.pdf
 
MERCURY TOXICITY.pptx
MERCURY TOXICITY.pptxMERCURY TOXICITY.pptx
MERCURY TOXICITY.pptx
 
lead.pptx
lead.pptxlead.pptx
lead.pptx
 
Copper toxicity
Copper toxicityCopper toxicity
Copper toxicity
 
Toxicity of Heavy Metals
Toxicity of Heavy MetalsToxicity of Heavy Metals
Toxicity of Heavy Metals
 
ARSENIC AND LEAD POISONING
ARSENIC AND LEAD POISONINGARSENIC AND LEAD POISONING
ARSENIC AND LEAD POISONING
 
Class chelating agents 1
Class chelating agents 1Class chelating agents 1
Class chelating agents 1
 
Metalic (Cu,fe,th,mg) poisoning
Metalic (Cu,fe,th,mg) poisoningMetalic (Cu,fe,th,mg) poisoning
Metalic (Cu,fe,th,mg) poisoning
 
Ana ppt. upload
Ana ppt.   uploadAna ppt.   upload
Ana ppt. upload
 
Presentation on iron poisoning
Presentation on iron poisoningPresentation on iron poisoning
Presentation on iron poisoning
 
Heavy metal poisoning
Heavy metal poisoningHeavy metal poisoning
Heavy metal poisoning
 
Metal toxicity presentation-Forensic
Metal toxicity presentation-Forensic Metal toxicity presentation-Forensic
Metal toxicity presentation-Forensic
 
Heavy metal toxicity
Heavy metal toxicityHeavy metal toxicity
Heavy metal toxicity
 
Heavy Metal Toxicity
Heavy Metal ToxicityHeavy Metal Toxicity
Heavy Metal Toxicity
 
Pharmacology of alcohol
Pharmacology of alcoholPharmacology of alcohol
Pharmacology of alcohol
 
Heavy metal poisoning PPT.pptx
Heavy metal poisoning PPT.pptxHeavy metal poisoning PPT.pptx
Heavy metal poisoning PPT.pptx
 

Plus de pctebpharm

Uterine relaxation
Uterine relaxationUterine relaxation
Uterine relaxation
pctebpharm
 
Thyroid hormone
Thyroid hormoneThyroid hormone
Thyroid hormone
pctebpharm
 
Quinolones and misc. antibiotics
Quinolones and misc. antibioticsQuinolones and misc. antibiotics
Quinolones and misc. antibiotics
pctebpharm
 
Prolactin hormone
Prolactin hormoneProlactin hormone
Prolactin hormone
pctebpharm
 
Hormonal contraceptives
Hormonal contraceptivesHormonal contraceptives
Hormonal contraceptives
pctebpharm
 
Endocrine system
Endocrine systemEndocrine system
Endocrine system
pctebpharm
 
Emetics and antiemetics
Emetics and antiemeticsEmetics and antiemetics
Emetics and antiemetics
pctebpharm
 
Chemotherapy of tuberculosis
Chemotherapy of tuberculosisChemotherapy of tuberculosis
Chemotherapy of tuberculosis
pctebpharm
 
Cephalosporins
CephalosporinsCephalosporins
Cephalosporins
pctebpharm
 
Appetite stimulant and
Appetite stimulant   andAppetite stimulant   and
Appetite stimulant and
pctebpharm
 
Adrenocotropic harmone
Adrenocotropic harmoneAdrenocotropic harmone
Adrenocotropic harmone
pctebpharm
 
Treatment of peptic ulcer
Treatment of peptic ulcerTreatment of peptic ulcer
Treatment of peptic ulcer
pctebpharm
 

Plus de pctebpharm (20)

Uterine relaxation
Uterine relaxationUterine relaxation
Uterine relaxation
 
Thyroid hormone
Thyroid hormoneThyroid hormone
Thyroid hormone
 
Tetracyclines
TetracyclinesTetracyclines
Tetracyclines
 
Sulfonamides
SulfonamidesSulfonamides
Sulfonamides
 
Quinolones and misc. antibiotics
Quinolones and misc. antibioticsQuinolones and misc. antibiotics
Quinolones and misc. antibiotics
 
Prolactin hormone
Prolactin hormoneProlactin hormone
Prolactin hormone
 
Laxatives
LaxativesLaxatives
Laxatives
 
Insulin
InsulinInsulin
Insulin
 
Hormonal contraceptives
Hormonal contraceptivesHormonal contraceptives
Hormonal contraceptives
 
Estrogens
EstrogensEstrogens
Estrogens
 
Endocrine system
Endocrine systemEndocrine system
Endocrine system
 
Emetics and antiemetics
Emetics and antiemeticsEmetics and antiemetics
Emetics and antiemetics
 
Chemotherapy of tuberculosis
Chemotherapy of tuberculosisChemotherapy of tuberculosis
Chemotherapy of tuberculosis
 
Cephalosporins
CephalosporinsCephalosporins
Cephalosporins
 
Carminatives
CarminativesCarminatives
Carminatives
 
Appetite stimulant and
Appetite stimulant   andAppetite stimulant   and
Appetite stimulant and
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
Adrenocotropic harmone
Adrenocotropic harmoneAdrenocotropic harmone
Adrenocotropic harmone
 
Vitamin d
Vitamin dVitamin d
Vitamin d
 
Treatment of peptic ulcer
Treatment of peptic ulcerTreatment of peptic ulcer
Treatment of peptic ulcer
 

Heavy metal and heavy metal antagonists

  • 1. Heavy metal and Heavy metal antagonists
  • 2. Heavy metals of concern are Lead Mercury Arsenic Cadmium Exert there toxic effects by combining with one or more reactive groups (Ligands) essential for normal physiological functions. Heavy metals may react in the body with- Ligands containing Oxygen- -OH, -COO - Ligand containing Sulfur- -SH Ligand containing Nitrogen- -NH 2
  • 3. Heavy metal antagonists (Chelating agents) are designed specifically to compete with these groups for the metals and prevent or reverse toxic effects and enhance the excretion of metals. Chelate - complex formed b/w a metal and a compound that contains two or more potential ligands. The stability of chelate varies with the metal and the ligand atoms. e.g- lead and mercury have greater affinities for sulfur and nitrogen than for oxygen.
  • 4.
  • 5.
  • 6. LEAD Primary source- leaded paints and drinking water environmental & industrial exposure Absorption, distribution and excretion Absorption – g.i.t & the respiratory system g.i.t absorption varies with age- Adults absorb upto 10% of ingested lead Children absorb upto 40% of ingested lead Iron deficiency also enhance intestinal absorption of lead.
  • 7. Distribution Once lead is absorbed , about 99% of that in the blood stream binds to hemoglobin in erythrocytes. initial distribution – in the soft tissues particularly tubular epithelium of kidney and in the liver In time- redistributed and deposited in bone, teeth & hair. Excretion- urinary excretion Because most of the lead is in the erythrocytes, very little is Filtered lead is also excreted in milk & sweat. Placental transfer of lead is also known.
  • 8.
  • 9. Acute hemolytic crisis sometimes occurs & cause severe anemia & hemoglobinuria. The kidneys are damaged & urinary changes are evident death may Occur in 1-2 days. CHRONIC LEAD POISONING Signs and symptoms may be divided into six categories 1. Gastrointestinal - Anorexia Muscle discomfort headache Constipation usually is an early sign
  • 10. 2 . Neuromuscular – muscle weakness easy fatigue occur long before actual paralysis 3. CNS- lead encephalopathy Most serious menifestation specially in children than in adults Early signs- vertigo, insomnia, restlessness, headache, irritability As encephalopathy develops- - patient may first become excited & confused -delirium with repetitive tonic-clonic convulsions & coma follows. -vomiting a common sign -visual disturbances
  • 11.
  • 12. Succinyl CoA + Glycine δ-aminolevulinate synthase δ-aminolevulinate (δ-ALA) δ-aminolevulinate dehydratase Porphobilinogen Uroporphobilinogen Coproporphyrinogen Protoporphyrin ferrochelatase +Fe 2+ Heme
  • 13. Diagnosis of lead poisoning -Children – lead in blood > 10µg/dl are at risk of Developmental disabilities -Adults- concentration >30µg/dl functional injury or Symptoms -Decrease in δ-aminolevulinate dehydratase activity - Increase in urinary excretion of δ-ALA & increase in Erythrocyte protoporphyrin Patients with lead concentration 30-75µg/dl have all the Above laboratory abnormality
  • 14.
  • 15.
  • 16. 1) CaNa 2 EDTA - initiated at a dose of 30-50mg/kg per day divided in two doses,either by deep i.m injection or slow i.v infusion for 5 consecutive days The first dose of CaNa 2 EDTA should be delayed until 4 hrs after the first dose of dimercaprol. An additional course may be given after an interruption of 2 days Each course of therapy should not exceed a total dose of 500mg/kg 2) Dimercaprol - 4mg/kg i.m route every 4 hrs for 48 hrs, then every every 6hrs for 48 hrs finally every 6-12 hrs for additional 7 days.
  • 17.
  • 18.
  • 19. Mechanism of action- It readly forms covalent bond with sulfur, & it is this property that accounts for most of the biological properties of the metal. Also combines with phosphoryl, carboxyl, amide and amine group.
  • 20.
  • 21. Concentration in urine- normal 5µg/liter TREATMENT Inorganic mercury - maintenance of fluid & electrolyte balance -emesis can be induced if patient is awake & alert chelation therapy Dimercaprol - 5mg/kg i.m initially,followed by 2.5mg/kg i.m every 12-24 hrs for 10 days. OR Penicillamine – 250mg orally every 6 hours
  • 22.
  • 23. ARSENIC - Found in soil, water and air as a common environmental Toxicant -Major source of occupational exposure to arsenic –containing Compounds is from manufacture of arsenical herbicides & pesticides. Mechanism of action Arsenate (pentavalent) is a well known uncoupler of mitochondrial oxidative phosphorylation. There is competitive substitution of arsenate for inorganic Phosphate in the formation of adenosine triphosphate
  • 24. Subsequent formation of an unstable arsenate ester that is rapidly hydrolysed (Arsenolysis). Toxicological effects of arsenic CVS- Acute & subacute doses induces mild vasodilation this leads to an edema, particularly facial. -hypotention -congestive heart failure -cardiac arrythmias GIT - -mild abdominal cramping -diarrhoea -severe gastroentritis associated with shock.
  • 25.
  • 26. Kidneys Severe renal damage Skin Hyperpigmentation in raindrop pattern Nervous system Encephalopathy Neurological lesions Liver- necrosis Carcinogenesis- skin tumors
  • 27.
  • 28. -nausea -vomiting -salivation -abdominal cramps Symptoms that appear in a few hours - irritation of respiratory tract with severe,early pneumonitis -chest pain -dizziness
  • 29. Chronic cadmium poisoning Kidney - proximal tubular injury proteinuria Lung - dyspnea Bone- osteomalacia Testis - testicular necrosis Treatment of cadmium poisoning - remove the patient from source -respiratory support
  • 30.